Martin M. Oken
183 works · 30,704 citations · h-index 61
Top works
- Toxicity and response criteria of the Eastern Cooperative Oncology Group
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma
- Distinctive Chromosomal Abnormalities in Histologic Subtypes of Non-Hodgkin's Lymphoma
- Prognostic effect of weight loss prior tochemotherapy in cancer patients
- Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
- Recurrent chromosomal defects are found in most patients with non-Hodgkin's-lymphoma
- Multiple Recurrent Genomic Defects in Follicular Lymphoma
- Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group
- bcl-2and Other Genomic Alterations in the Prognosis of Large-Cell Lymphoma
- Screening by Chest Radiograph and Lung Cancer Mortality
- Clinical and biologic implications of recurrent genomic aberrations in myeloma
- Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation
- Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia
- Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer
- Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemia
- Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study.
- Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients
- Lung Cancer Risk Prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Models and Validation
- Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study.
- A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma